Skip to main content
pCPA File Number:
22803
Negotiation Status:
Concluded with an LOI
Indication(s):
Atopic dermatitis
Sponsor/Manufacturer:
Eli Lilly Canada Inc.
CDA-AMC Project Number:
SR0819-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: